Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

37 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Driver KIT mutations in melanoma cluster in four hotspots.
Dumaz N, André J, Sadoux A, Laugier F, Podgorniak MP, Mourah S, Lebbé C. Dumaz N, et al. Among authors: podgorniak mp. Melanoma Res. 2015 Feb;25(1):88-90. doi: 10.1097/CMR.0000000000000116. Melanoma Res. 2015. PMID: 25304235
Validation of a preclinical model for assessment of drug efficacy in melanoma.
Delyon J, Varna M, Feugeas JP, Sadoux A, Yahiaoui S, Podgorniak MP, Leclert G, Dorval SM, Dumaz N, Soulie J, Janin A, Mourah S, Lebbé C. Delyon J, et al. Among authors: podgorniak mp. Oncotarget. 2016 Mar 15;7(11):13069-81. doi: 10.18632/oncotarget.7541. Oncotarget. 2016. PMID: 26909610 Free PMC article.
EMMPRIN/CD147 is an independent prognostic biomarker in cutaneous melanoma.
Caudron A, Battistella M, Feugeas JP, Pages C, Basset-Seguin N, Mazouz Dorval S, Funck Brentano E, Sadoux A, Podgorniak MP, Menashi S, Janin A, Lebbé C, Mourah S. Caudron A, et al. Among authors: podgorniak mp. Exp Dermatol. 2016 Aug;25(8):618-22. doi: 10.1111/exd.13022. Epub 2016 May 20. Exp Dermatol. 2016. PMID: 27060463
Clinical value of early detection of circulating tumour DNA-BRAFV600mut in patients with metastatic melanoma treated with a BRAF inhibitor.
Louveau B, Tost J, Mauger F, Sadoux A, Podgorniak MP, How-Kit A, Pages C, Roux J, Da Meda L, Lebbe C, Mourah S. Louveau B, et al. Among authors: podgorniak mp. ESMO Open. 2017 Jun 21;2(2):e000173. doi: 10.1136/esmoopen-2017-000173. eCollection 2017. ESMO Open. 2017. PMID: 28761746 Free PMC article. No abstract available.
Discoidin domain receptors: A promising target in melanoma.
Reger de Moura C, Battistella M, Sohail A, Caudron A, Feugeas JP, Podgorniak MP, Pages C, Mazouz Dorval S, Marco O, Menashi S, Fridman R, Lebbé C, Mourah S, Jouenne F. Reger de Moura C, et al. Among authors: podgorniak mp. Pigment Cell Melanoma Res. 2019 Sep;32(5):697-707. doi: 10.1111/pcmr.12809. Epub 2019 Jul 22. Pigment Cell Melanoma Res. 2019. PMID: 31271515
A novel tumor suppressor function of Kindlin-3 in solid cancer.
Djaafri I, Khayati F, Menashi S, Tost J, Podgorniak MP, Sadoux A, Daunay A, Teixeira L, Soulier J, Idbaih A, Setterblad N, Fauvel F, Calvo F, Janin A, Lebbé C, Mourah S. Djaafri I, et al. Among authors: podgorniak mp. Oncotarget. 2014 Oct 15;5(19):8970-85. doi: 10.18632/oncotarget.2125. Oncotarget. 2014. PMID: 25344860 Free PMC article.
A targeted genomic alteration analysis predicts survival of melanoma patients under BRAF inhibitors.
Louveau B, Delyon J, De Moura CR, Battistella M, Jouenne F, Golmard L, Sadoux A, Podgorniak MP, Chami I, Marco O, Caramel J, Dalle S, Feugeas JP, Dumaz N, Lebbe C, Mourah S. Louveau B, et al. Among authors: podgorniak mp. Oncotarget. 2019 Mar 1;10(18):1669-1687. doi: 10.18632/oncotarget.26707. eCollection 2019 Mar 1. Oncotarget. 2019. PMID: 30899440 Free PMC article.
37 results